Vital Signs Solutions receives backing to facilitate mass-scale antibody testing for COVID-19
.jpg)
The company will adapt its digital platform to digitize any COVID-19 antibody rapid test assay and embed this within an app available on smartphones and tablets.
Vital Signs Solutions, an early-stage, startup developing innovative, digital preventative healthcare solutions, has been awarded a significant grant by Innovate UK as part of the UK Government's support for innovation that can alleviate the effects of the COVID-19 crisis.
The company will adapt its digital platform, called PocDoc, to digitize any COVID-19 antibody rapid test assay and embed this within an app available on smartphones and tablets.
The app will be able to collect additional data to help track and analyse the spread of the virus and its impact on the presence of antibodies in the population.
The first version of the app has been finished and will be undergoing real-world beta testing in the coming weeks.
In addition to its efforts to help tackle COVID-19, Vital Signs Solutions is continuing to develop its own range of physical blood tests that are integrated with its PocDoc platform, with results delivered immediately via the PocDoc app.
Steve Roest, CEO of Vital Signs Solutions, commented: A digital platform is critical to facilitate the scaling of antibody testing and we are confident our PocDoc platform can be adapted to solve this problem."
Related News
-
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Sharp seeks greater foothold in Chinese market through ClinsChain partnership
Sharp hopes teaming up with clinical service provider ClinsChain will open the door to the Chinese market -
News GSK spins off consumer arm Haleon in biggest European listing for a decade
Haleon becomes the world’s biggest consumer health business, but debuted with a lower-than-expected valuation -
News SIGA reports $28M worth of new orders for monkeypox antiviral
The company has seen a sharp uptick in orders for its oral treatment as monkeypox cases rise globally -
News New CPHI report looks at CDMO outsourcing and partner selection
In The Future of Outsourcing - Strategies for Partner Selection, experts from across the pharma industry look at current trends impacting the contract services landscape and gauge the merits and drawbacks of the most common outsourcing strategies ... -
News CureVac files patent infringement lawsuit against BioNTech over mRNA technology
Company is seeking ‘fair compensation’ for alleged infringement of intellectual property rights relating to the use of mRNA tech to create the Pfizer-BioNTech COVID-19 vaccine -
News Investors turn attention to biotechs with clear path to market
Companies that are further down the road to market are more attractive to investors than those in early development -
News Tonix strives for pandemic readiness with new US manufacturing facility
The company's goal is to design and test new vaccines for novel pathogens within 100 days of a potential pandemic threat
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance